BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 64327)

  • 1. Inhibition of human lymphocyte transformation by human alpha-foetoprotein (HAFP); comparison of foetal and hepatoma HAFP and kinetic studies in vitro immunosuppression.
    Yachnin S; Lester E
    Clin Exp Immunol; 1976 Dec; 26(3):484-90. PubMed ID: 64327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human lymphocyte transformation by human alpha-fetoprotein (HAFP); HAFP monomers and multimers and a resistant lymphocyte subpopulation.
    Yachnin S; Lester EP
    J Immunol; 1977 Aug; 119(2):555-7. PubMed ID: 69662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid interactions with human alpha-fetoprotein (AFP). A study of the role of such interactions in the ability of human AFP to suppress lymphocyte transformation.
    Yachnin S; Getz GS; Lusk L; Hsu RC
    Oncodev Biol Med; 1980; 1(4-5):273-85. PubMed ID: 6169064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of the inhibitory effect of human alpha-fetoprotein on in vitro transformation of human lymphocytes.
    Yachnin S
    Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2857-61. PubMed ID: 60761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human lymphocyte transformation by human alpha-foetoprotein (HAFP): studies on the mode of HAFP action and the role of HAFP polymorphism.
    Lester EP; Miller JB; Baron JM; Yachnin S
    Immunology; 1978 Feb; 34(2):189-98. PubMed ID: 75181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human alpha-fetoprotein as a modulator of human lymphocyte transformation: correlation of biological potency with electrophoretic variants.
    Lester EP; Miller JB; Yachnin S
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4645-8. PubMed ID: 63952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of seminal plasma and its fractions on in vitro blastogenic response to mitogen.
    Majumdar S; Bapna BC; Mapa MK; Gupta AN; Devi PK; Subrahmanyam D
    Int J Fertil; 1982; 27(4):224-8. PubMed ID: 6131041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of alpha-fetoprotein and other serum factors derived from hepatoma-bearing rats on the mixed lymphocyte response.
    Parmely MJ; Thompson JS
    J Immunol; 1976 Nov; 117(5 Pt.2):1832-7. PubMed ID: 62791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A postsynthetic modification of human alpha-fetoprotein controls its immunosuppressive potency.
    Lester EP; Miller JB; Yachnin S
    Proc Natl Acad Sci U S A; 1977 Sep; 74(9):3988-92. PubMed ID: 71737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunization with dendritic cells infected with human AFP adenovirus vector effectively elicits immunity against mouse hepatocellular carcinomas].
    Tan XH; Zhu Q; Liu C; Liu XL; Shao XT; Wei B
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):13-6. PubMed ID: 16737612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of inhibition by mouse alpha-foetoprotein (AFP) of in vitro induced lymphocyte blastogenesis.
    Hassoux R; Poupon MF; Uriel J
    Ann Immunol (Paris); 1978; 129(2-3):275-85. PubMed ID: 79328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-fetoprotein (AFP)-derived peptides as epitopes for hepatoma immunotherapy: a commentary.
    Mizejewski GJ
    Cancer Immunol Immunother; 2009 Feb; 58(2):159-70. PubMed ID: 18612637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides.
    Butterfield LH; Ribas A; Dissette VB; Lee Y; Yang JQ; De la Rocha P; Duran SD; Hernandez J; Seja E; Potter DM; McBride WH; Finn R; Glaspy JA; Economou JS
    Clin Cancer Res; 2006 May; 12(9):2817-25. PubMed ID: 16675576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells.
    González-Carmona MA; Märten A; Hoffmann P; Schneider C; Sievers E; Schmidt-Wolf IG; Sauerbruch T; Caselmann WH
    Liver Int; 2006 Apr; 26(3):369-79. PubMed ID: 16584401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of lymphocyte proliferation by sera from patients with hepatocellular carcinoma: lack of correlation with serum alpha-fetoprotein levels.
    Ren EC; Chan SH
    J Natl Cancer Inst; 1981 Apr; 66(4):625-30. PubMed ID: 6164810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immune responses of dendritic cells after loaded with cytotoxicity T lymphocyte epitope based peptide of human alpha-fetoprotein (hAFP)].
    Guo J; Cai M; Wei D; Qin L; Huang J; Wang X
    Zhonghua Gan Zang Bing Za Zhi; 2002 Jun; 10(3):178-80. PubMed ID: 12113671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and function of CXC and CC chemokines in human malignant liver tumors: a role for human monokine induced by gamma-interferon in lymphocyte recruitment to hepatocellular carcinoma.
    Yoong KF; Afford SC; Jones R; Aujla P; Qin S; Price K; Hubscher SG; Adams DH
    Hepatology; 1999 Jul; 30(1):100-11. PubMed ID: 10385645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human alpha-fetoprotein: immunosuppressive activity and microheterogeneity.
    Lester EP; Miller JB; Yachnin S
    Immunol Commun; 1978; 7(2):137-61. PubMed ID: 77248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human serum albumin as a substitute for foetal calf serum in blast transformation assays and cytogenetic analyses.
    Drouin R; Harvey P; Richer CL; Rémy-Prince S; Montplaisir S
    Cytobios; 1987; 52(210-211):193-207. PubMed ID: 3428005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-fetoprotein and human lymphocyte subpopulations.
    Gupta S; Good RA
    J Immunol; 1977 Feb; 118(2):405-8. PubMed ID: 65422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.